Pages

Showing posts with label Europe. Show all posts
Showing posts with label Europe. Show all posts

Tuesday, 22 December 2015

"How Greece saved my 2015 tips dullness"

I wrote a piece titled "How Greece saved my 2015 tips dullness" which was uploaded just now to the ShareProphets website.  You can find a link to the piece (free sign-up) here.

Thursday, 3 December 2015

ECB policy day: why I disagree with "Draghi has over promised and under delivered"

Should we really be disappointed?  In summary a broadly 'as expected' rate cut and an extension of both the composition and duration of the ECB's QE program seems like a clear step-up to me reflecting (still) below trend regional European growth and the need to do something.  Draghi is balancing the realities of a still split policy board with a wide range of views including classical monetarists worried about sharply boosted money supply growth:


(from today's Financial Times)

The reality is that you buy on the rumour and you sell on the fact.  The euro was oversold and so it snaps back.  Frankly all things considered it does remain undervalued versus my instinct of a fair value against the US dollar (of 1.15) even adjusting for different positions in the monetary policy cycle and related.  

Today's decisions indicate on the big asset classes that bond investors should be concerned.  Why?  Well we know that European bond yields are far too low...


...and exhibiting bad relative value: 


Therefore you end up with this (below) today given inflation generation hopes to much nearer the 2% target level are fully reiterated today: 



 So if you should be anticipating a higher euro and a lack of returns in bonds, what about European equities?  For me a continued lack of structural reforms in Europe plus a general lack of cohesion (migrant crisis, political angst) cannot fill you with huge confidence but the above shifts imply specific sectors have the scope to outperform.  Why?  Pick-up yield value and low general sentiment.  For me the two naturally meet in certain sectors that traditionally perform at the time of a bond yield increase:

Much to do in the European multi-asset class space. I see specific and not general opportunity especially in equities.  Got to be active...

Tuesday, 27 October 2015

Tuesday earnings season wrap - Europe (BP, BASF, Novartis)

A big earnings day to say the least.  First stop for a wrap/review is Europe where four corporate earnings catch my attention.

I have covered BP already today here and listening to the conference and leafing through the presentation document I got akin feelings.  The three key charts from the presentation were clearly the ones below given (as I noted in my linked article above the importance of the sustainability of the dividend and not trading off on the growth potential of the company.

On the dividend as noted below the company despite ongoing cost control efforts is not yet covering its use of cash flow obligations...

...and hence is going to be dependent on a few billion dollars worth more of disposals to keep gearing below 20%.  Not a high statistic in absolute terms but an important one for the company to keep close to.  I think they do and the dividend keeps flowing.  


As for the growth potential trade-off...well even though I do not expect material growth from the company the below graphic notes continuing construction and design level potential.  US$15bn pa capex should buy you something other than field maintenance...


My view is as noted at the above link: BP shares should move neatly into the 400s during the next year.  Of course inherent within this is a call that oil prices are not going to dump materially further - as mentioned in the earlier piece the usual impact of the oil majors cutting capex materially is for the supply/demand dynamic to naturally get tighter.  


Staying with oil related stocks, numbers from chemical giant BASF were notable for their pulled back guidance ('ebit before special items is expected to be slightly below the level of 2014') and from their in-house economics team's pulling back of industrial production and oil price assumptions. 


Ah...the oil price.  Typically for a chemicals company a lower oil price hurts pricing efforts and this was certainly the case with these Q3 BASF numbers with only the agricultural sector (noted above as struggling at the earnings line): 

Other notable factors?  Good free cash flow...although note the big working capital swing (any recovery and watch that reverse).  


The shares clearly have some technical support at c. Euro65 and fundamentally I note achieving Euro8bn of ebit (FY14A came in just below this level as will apparently FY15e) and valuing this at x8 EV/ebit would suggest just below a Euro70 level is of interest.  Net net with a near 4% yield and fundamentally sensible positioning (including inevitably some euro correlation) sub Euro70 BASF shares would flash as 'interesting' (with augmentation levels each Euro5 down).  


As for Novartis I have talked about the Swiss healthcare name as being safe/steady but just a bit 
expensive.  That remains the case despite the share coming off the highs of three months ago:


Fundamentally there is no fire at Novartis despite the eyewear Alcon unit struggling.  Pricing and generic challenges were countered by core product growth in both the pharmaceutical and generics units and debt - despite heightened by the GlaxoSmithKline asset swap - remains relatively modest.  


Back in July - at around CHF100 a share - I was a seller but here at around CHF90 I am more of a holder.  Not overly inspired though - at prevailing give me their Swiss peer Roche any day.  

Wednesday, 21 October 2015

Earnings catch-up: Europe (Whitbread, Syngenta, ABB)

So many numbers out over the last couple of days...it has been hard to keep up especially as I have been putting the finishing touches to a couple of presentations.  A few thoughts however first on European stocks and then American ones.

Whitbread numbers were pretty solid.  Unfortunately the shares in the Premier Inns and Costa Coffee operator never fell to levels that were compelling enough for me as detailed in my extensive write-ups back in 2013 (link here).


As written up outside of Financial Orbit published output I became very cautious in the £50s zone but what to think here in the upper £40s following a reiteration of their core medium-term targets?


Clearly this is still a company (albeit soon under a new CEO) which is firing on all cylinders.  One quick slide on the core Premier Inns... 


...and Costa Coffee units.  Impressive customer satisfaction levels.

So with c. a 25% growth in capacity for both core units in the UK (even before international expansion efforts - which appear to be progressing fine) is a reasonable blue sky profitability (say) a third higher than today?

That would put prospective profitability nearer £700m and with an EV (non lease adjusted) of over £9bn there is a little bit of potential upside on a (say) x14 EV/ebit multiple.  

Of course this is on something like a perfect execution and of course the company has to deal with various challenges including the UK Living Wage (inducing the first coffee price rise for a few years at Costa). 

In short, today the opportunity for Whitbread investment initially lays sub £45 with a double up at £40 in my view.  I have noted down the levels. 

On Twitter I noted earlier concerning Syngenta that: 

Too right time for new leadership. Failed re bid. Shares should like this " CEO to step down "

The c. 6% rise in the share price today brings us back approximately to the CHF330 under which I noted that I thought the shares were cheap (link here). Syngenta remains a strong hold at prevailing in my view.  I know the Syngenta Chairman has come out (as per this piece on Seeking Alpha) saying that the resignation of Mike Mack 'did not arise from a difference over the company's strategy or its rejection of MON's takeover offer' but surely he knew the writing was on the wall.  

Now what Syngenta needs to do is refocus on fundamentals, hit those cost cutting and cash flow generation targets and with a fairer wind from underlying agricultural demand - and not such a dogmatic attitude on M&A - a CHF400 share price is plausible. 

Staying in Switzerland, the stand-out chart for me from the ABB numbers was this one citing 'continued hard weather sailing': 


Certainly the lack of order progression geographically is notable but a book-to-bill of over x1 and a cash conversion in excess of 100% has its own signalling reward.  The key positive is the continued turnaround plan centred on cost cutting.  

I was too early in calling the shares a 'buy' a year ago (link here) but this high teens CHF share price double bottom is opportunistic.  I bought more stock at the height of the Swiss franc revaluation in January/February this year and my instinct is that with the shares currently trading at a barely double digit static EV/ebit valuation and a well-covered 4%+ dividend yield (plus buyback), ABB is a thematic longer cycle industrial business to believe in.  You can imagine what the switch chart with GE (link here for my latest research on that name, which I am still a buyer on) looks like. 


Monday, 19 October 2015

Danone - strong conference call (and correctly recently a stronger share price)

The last time I wrote about Danone I observed the need to take profits (link here). Since then the shares have fallen over 10% (15%+ at the market nadir) and I turned more positive on them again (albeit not published on Financial Orbit). 

Some Q3/9m sales only numbers from Danone this morning.  Whilst the headlines note FY15 numbers/hopes reiteration what first struck me was that value kept on outpacing volumes i.e. the company was still placing pricing above sales.  In other words the pricing power I have previously discussed continues (all four key divisions – Dairy, Water, Child Nutrition & Medical Nutrition) had positive pricing). 

Another interesting aspect was that despite a ‘challenging environment…in some emerging markets’ (Russia, Brazil), Danone also noted ‘different dynamics between different geographies’.  You can see this in the chart below.  And which is the strongest performing geography?  Europe…


What was particularly behind this notably stronger performance in Europe was the continuing improvement in the Dairy division:

Dairy – ‘key positive trends’.  Europe: ‘volumes are improving…every country is improving…the deflation (in milk prices) will not last…but will go on longer than previously expected due to inventories’ (given Danone is a purchaser of milk raw materials no bad thing).  Also guiding do not see a major global pricing war.

The focus on pricing was very apparent with the observation that in Europe the aim was to ‘return to growth in as profitable manner as we can':


Water – as noted by Nestle last week this area is showing good growth currently. Danone noted the division ‘benefited from good weather…strong Evian and Volvic brands…believe have the right combination of brands to capture this opportunity in full’. 

Child Nutrition – continued to bounce back in countries like China as ‘Chinese market performance continues to be supported by the success of international brands’. 




Pulling it all together Danone had ‘Three messages…strong foundations…progressing in changing our model and investing in future growth…environment is challenging…so strengthening the resilience of our business model…focused on profitable sustainable growth’.  In practical terms what this meant was that the full year guidance was confirmed: 


Elsewhere (back in July at the time of the H1 numbers) I noted that below Euro60 offered opportunities (mid-teens prospective EV/ebita, optionality as the company continued to drive efficiency as per their 2020 efficiency drive business targets etc.).  That remains my view. 
With the share just below the Euro60 level the shares just remain a ‘BUY’ but are close to flicking into ‘HOLD’.  Overall excellent conference call however reiterating that Danone is clearly a preferred name in the Europe-listed consumer space (far more attractive at-the-margin versus say a Nestle). 


Wednesday, 14 October 2015

ASML: ' shipment expectations have changed...due to customer uncertainty'

It has been a couple of years since I last wrote formally about ASML the Dutch listed company with a dominant share in lithography systems for semiconductor companies. The way to think about it is that they enable chipsets to get smaller which still is a very clear trend. The key is always technology and two years ago I used this excellent chart to highlight this...


Today's update from the company feels to me like a classic short-term versus long-term.  Longer-term the company is still very comfortable with multi-year targets like Euro10bn worth of revenues by 2020 (implied CAGR c. 8%+).  But, as the outlook chart in their presentation noted, corporate life is not the easiest as the moment reflecting corporate capex uncertainty:
'Foundries are slightly more cautious with their investment plans' is important for the company given the split of the backlog as noted below: 


In addition the aforementioned great white technological hope EUV is not ramping quite as fast as expected:

EUV: 'shipment expectations have changed...4 from 7...due to customer uncertainty'.  But hopeful of the future given public comments by customers but timing has been pushed out. 'EUV a question of when not if' 

And in terms of the other demand relevant comments from the call here a few highlights:

Memory 'customers indicating that system demand will continue at healthy levels'

NAND - 'limited lithography shipments...sales could be down year-on-year'

Logic - 'more cautious stance' re capex

'10nm ramp is very real...but will not start before Q2 (2016)...will provides customers with very attractive nodes...but (application) is not as simple as customers thought'

So what to make of all this?  Clearly capex is currently lumpy - no huge surprises given some volatility in chip industry corporate profitability.  Numbers-wise however the last rolling twelve months has generated over Euro1.5bn in operating income and over Euro1bn in free cash.

Too much to extrapolate such numbers?  In a fast-moving area there is going to be high variability but maybe not.  Nevertheless at a c. Euro31bn EV it still implies a x20+ EV/ebit and 3%+ free cash flow yield (although the company has continued to distribute proportionately more than this).


So overall thoughts: interesting company, fascinating technology and a clear market leader.  I like the debt-free balance sheet and willingness to return capital but any trade here is either responding to high market volatility (note the transitory fall to c. Euro70 in the volatility of the last couple of months) or longer-term.  We are at neither at the moment but I have put a flag at Euro70. 

Monday, 5 October 2015

Another management team grasps share price defeat from bid approach glory

After writing in late August about the ability of the management of Syngenta to grasp defeat from the jaws of share price victory by turning down the attractive Monsanto bid (link here) it appears that we have another example in an akin agriculture and related space with the news that Potash Corp have withdrawn their bid for K+S.  Or as this article  puts it:

·         Canadian fertilizer producer cites lack of engagement with K+S
·         Probe said to stoke concerns over need for due diligence

Oh dear me.  Suffice to say - just like Syngenta before them - K+S' share price has headed sharply south today:

Yes, a price in the Euro23s is right back near the 2015 YTD lows and over 40% below the high achieved in the halcyon post-bid days in late June/early July.  

I noted in July that Potash Corp would probably have to go hostile to grab hold of K+S and even worked out a notional bid level of Euro45/share 

'But - for control...Potash Corp are going to have to bid Euro45+ for a chance to own K+S.  As the latter's management noted on today's conference call when asked about a more dynamic scenario like a hostile bid: 

'the shareholders have to decide...and we will respect their decision' '

I also observed that:

'All of these are ifs and buts though because any broader tension in the potash (especially) market moves around that division's multiple/valuation materially'

And hasn't the volatility in both financial and agricultural markets done just that and to such an extent that a few weeks ago after global fertiliser peer Mosaic profit warned I observed (link here):

'...from today's perspective K+S shareholders should have bitten the hand off of Potash Corp at Euro41+ a share'

Of course - to be more precise - K+S shareholders should have sold their shares in the market as the company's management were unwilling to work with the bidder - and this risked problems.

Bids have issues especially in volatile markets but this semi-arrogant unwillingness of management teams to engage is doubly problematic.  Sure they have pride at stake but ultimately to refuse point-blank to open the books up to clearly well-financed bidders is ludicrous - and shareholders need to steer clear / sell their shares in such a situation.

As noted in the link in the first paragraph of this piece I replaced the Syngenta shares I had sold on the announcement of bid after the proposed Monsanto deal fell away. I am not a K+S shareholder (and have not been for many years) and the company's (in my opinion) non first tier position does not attract me at prevailing prices.  I have looked at Potash Corp shares before and in a separate article during the week will look at them again given they are still kicking around levels last seen at the nadir of the global financial crisis...


...my major thought however is for shareholders to be very cautious of management teams who do not engage.  There is one aspect to be fighting for the best deal (which should in any case be put to a shareholder vote) it is quite another to not even meet to discuss the bid approach with the potential acquiror.  As both Syngenta and K+S incumbent management will now find out unless they can pull some financial rabbits out of the corporate hat shareholder agitation is highly likely at upcoming quarterly results/AGMs.  

Thursday, 3 September 2015

Chart-fest from one of Europe's most interesting companies

I know, I know, Europe and interesting companies maybe classically recently do not go very well together.  However it is well worth taking a look at Umicore a Belgian company which made the cut for top 15 stocks for 2015 I put together near the turn of the year.  At least the share is still up on the year (albeit well down from the mid-year high):


Today (Wednesday) Umicore held a capital markets day. CMDs often provide fascinating insights and having paced through all the Umicore executive presentations here are the best charts and slides from my perspective:

First...who are Umicore?  Well, they have important positions in (precious) metals recycling, auto/truck catalysts and some more specialist energy/surface technologies businesses. 

And these positions include some strong incumbent positions: 


However the European financial crisis/malaise no doubt did not help them hit their first half of this decade targets...

...however the company still has optimism about the acceleration scope in revenues/ebitda: 

So why such optimism?  Tightening optimism in the auto/truck catalyst areas help...

...as well as inherent growth in this space (slightly higher in the 'heavy duty' area i.e. trucks/related):
Elsewhere the company sees strong growth in the battery/related areas especially in the rechargeable sub-space:
Strong dynamics in rechargeable battery materials is driven by vehicle electrification but it is not the only growth area in this broad space: 
 Whilst catalyst and battery/related operations are strong, recycling remains the strongest sub-sector that Umicore have...

...and this is centred on a unique (precious) metals recycling position centred on their world leading Hoboken plant: 

 Bringing this all together the company anticipates doubling earnings by 2020 implying a CAGR nicely into the double digit range:

...which should offer opportunities to continue to augment the current 2.8% dividend yield given the strong balance sheet where net debt to ebitda is just x0.6.  


 Bottom line Umicore remains a fascinating thematic company with good growth prospects.  A just above x12 EV/ebit rating based on their FY15e guidance equates to a good value entry point for investors in my view especially given the aforementioned near 3% dividend yield plus a strong balance sheet. The shares should be deep into the Euro40s in my view.

Monday, 24 August 2015

"Equity market inspiration...from my first Yahoo Finance Contributors article"

My latest post as a Yahoo Finance Contributor titled "Equity market inspiration...from my first Yahoo Finance Contributors article" can be found here.

Thursday, 20 August 2015

"Stock Spirits and the Polish vodka market"

I wrote a piece titled "Stock Spirits and the Polish vodka market" which was uploaded just now to the ShareProphets website.  You can find a link to the piece (free sign-up) here.